Deo Pharmaceuticals Private Limited
About Deo Pharmaceuticals Private Limited
Data last updated:
Deo Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2004PTC054831. Its GSTIN is 33AACCD1212E1ZK (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.43 Lakh. It is led by directors including Somasekharan Suresh Babu and Ramalingaiyar Sadhanantham.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.60/61 Krishna Industrial Estate Vanagaram Mettukuppam, Chennai, Tamil Nadu, India – 600095.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.09 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net loss of ₹17.13 Lakh (net margin -15.7%) and EBITDA of -₹11.94 Lakh (EBITDA margin -10.9%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹1.17 Cr on record. Court records list 22 cases involving the company, including 21 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.60/61 Krishna Industrial Estate Vanagaram Mettukuppam, Chennai, Tamil Nadu, India – 600095
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Deo Pharmaceuticals Private Limited
The main business activity of Deo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Deo Pharmaceuticals Private Limited FY 2025 filings available
Deo Pharmaceuticals Private Limited reported revenue of ₹1.09 Cr (up 53% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Deo Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 53% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Deo Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹11.94 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹17.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Deo Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -15.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Deo Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Deo Pharmaceuticals Private Limited
Deo Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somasekharan Suresh Babu | Director | 06 Dec 2004 | 21 Years 10 Months | Current |
| Ramalingaiyar Sadhanantham | Director | 12 Jan 2007 | 19 Years 9 Months | Current |
| Jayanthi | Alternate Director | 06 May 2025 | 1 Years 5 Months | Current |
Peer Comparison of Deo Pharmaceuticals Private Limited
Deo Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cynthogen Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | •••• | •••• | 467.0% | •••• | Bangalore, Karnataka, India |
| Addition Aromatics Chemical Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | -69.0% | •••• | Ahmedabad, Gujarat, India |
| Aronation Life Care Private Limited | ₹1.09 Cr (FY 2022) | •••• | •••• | 474.0% | •••• | Kangra, Himachal Pradesh, India |
| Evapride Healthcare Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | 143.0% | •••• | Pune, Maharashtra, India |
| Giselbert Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | 1815.0% | •••• | Narendranagar, Uttarakhand, India |
| Deo Pharmaceuticals Private Limited this company | ₹1.09 Cr (FY 2024) | •••• | •••• | 53.0% | •••• | Chennai, Tamil Nadu, India |
| Shiv Herbal Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Nagpur, Maharashtra, India |
| Mandakini Pharmaceuticals and Distributors Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Mayurbhanj, Odisha, India |
| Uni Biotech Healthcare Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Panchkula, Haryana, India |
| Bora Pharma Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Ahmednagar, Maharashtra, India |
| Quorum Biotech Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Deo Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Deo Pharmaceuticals Private Limited
Deo Pharmaceuticals Private Limited is audited by D.V.BADARINARAYANA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D.V.BADARINARAYANA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Deo Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Deo Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2019 | State Bank of India | ₹49 Lakh | Open |
| 23 Mar 2010 | State Bank of Travancore | ₹7.2 Lakh | Open |
| 08 Aug 2007 | State Bank of Travancore | ₹6.1 Lakh | Open |
| 02 Jun 2007 | State Bank of Travancore | ₹47 Lakh | Open |
| 26 May 2007 | State Bank of Travancore | ₹7.5 Lakh | Open |
Total charge records: 5 View all charges
Legal Cases of Deo Pharmaceuticals Private Limited
Deo Pharmaceuticals Private Limited has 22 court cases on record: 21 filed by Deo Pharmaceuticals, 1 filed against it. 1 case is pending and 21 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 18 | 1 | 0 |
| High courts | 4 | 0 | 1 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Tiruvallur, Tamil Nadu | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
| District court, Tiruvallur, Tamil Nadu | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
| District court, Tiruvallur, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
| Madras High Court | Court case (CRL MP) | Filed by the company against State of Tamilnadu | Disposed |
Full case history
All 22 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Deo Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Deo Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Deo Pharmaceuticals Private Limited
Deo Pharmaceuticals Private Limited has 5 board changes on record since 2004: 4 appointments and 1 cessation. The latest: Jayanthi was appointed as Alternate Director on 06 May 2025.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Deo Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Deo Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Deo Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Deo Pharmaceuticals Private Limited
Deo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCD1212E1ZK | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Deo Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deo Pharmaceuticals Private Limited
Deo Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 December 2004 (22+ years old) and is registered under CIN U24231TN2004PTC054831.
Deo Pharmaceuticals reported revenue of ₹1.09 Cr for FY 2024 (up 53% YoY).
Deo Pharmaceuticals has 3 current directors:
- Somasekharan Suresh Babu - Director
- Ramalingaiyar Sadhanantham - Director
- Jayanthi - Alternate Director
Deo Pharmaceuticals reported a net loss of ₹17.13 Lakh (net margin -15.7%) and EBITDA of -₹11.94 Lakh (EBITDA margin -10.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Deo Pharmaceuticals is -42% over three years and 2% over five years. In the latest year (FY 2024) revenue rose 53%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Deo Pharmaceuticals is 33AACCD1212E1ZK, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Deo Pharmaceuticals is U24231TN2004PTC054831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deo Pharmaceuticals has 22 court cases on record: 21 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Deo Pharmaceuticals was incorporated on 06 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Deo Pharmaceuticals by revenue are Cynthogen Pharmaceuticals Private Limited, Addition Aromatics Chemical Private Limited, Aronation Life Care Private Limited, Evapride Healthcare Private Limited, Giselbert Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Jayanthi was appointed as Alternate Director on 06 May 2025. Perumal Pillai Somasekharan ceased to be Director on 31 Mar 2020. Ramalingaiyar Sadhanantham was appointed as Director on 12 Jan 2007. Deo Pharmaceuticals has 5 board changes on record in total.